Publication:
Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Memur, Seyma

Korkmaz, Levent

Bastug, Osman

GÜNEŞ, TAMER

Kurtoglu, Selim

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

The activation of the hypothalamic-pituitary-gonadal axis observed during the first month of life is thought to be a significant phase in the maturation of gonads and potentially be important for the development of reproductive functions. The preterm ovarian hyperstimulation syndrome (POHS) was first detected at postconception 36-39 weeks in a preterm female newborn with edema developing in the vulva, the hypogastric site, and the upper leg. The pathophysiology of this postnatal hormonal change is obscure. In this paper we would like to present a case developing POHS and to discuss possible pathophyslogical mechanisms.

Description

Source

Keywords

Keywords

Citation

Halis H., Memur S., Korkmaz L., Bastug O., GÜNEŞ T., Kurtoglu S., -Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate-, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.27, ss.997-999, 2014

Collections

Endorsement

Review

Supplemented By

Referenced By

1

Views

0

Downloads

View PlumX Details


Sustainable Development Goals